Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,264,423

« Back to Dashboard

Summary for Patent: 5,264,423

Title: Inhibitors for replication of retroviruses and for the expression of oncogene products
Abstract:Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.
Inventor(s): Cohen; Jack S. (Bethesda, MD), Neckers; Len (Bethesda, MD), Stein; Cy (Gaithersburg, MD), Loke; She L. (Wheaton, MD), Shinozuka; Kazuo (Kazo, JP)
Assignee: The United States of America as represented by the Department of Health (Washington, DC)
Application Number:07/976,733
Patent Claim Types:
see list of patent claims
Use; Compound; Composition;

No matches for this query

International Patent Family for Patent: 5,264,423

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0288163► Subscribe
Germany3852714► Subscribe
Canada1322723► Subscribe
Australia619180► Subscribe
Australia1571788► Subscribe
Austria116857► Subscribe
Israel85827► Subscribe
JapanH01503302► Subscribe
JapanH0559120► Subscribe
World Intellectual Property Organization (WIPO)8807544► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: